fluphenazine enanthate has been researched along with Schizophrenia in 14 studies
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effects of fluphenazine decanoate and enanthate versus oral anti-psychotics and other depot neuroleptic preparations for individuals with schizophrenia in terms of clinical, social and economic outcomes." | 8.91 | Fluphenazine decanoate (depot) and enanthate for schizophrenia. ( Adams, CE; Asher, R; David, A; Eisenbruch, M; Jayaswal, A; Maayan, N; Quraishi, SN; Rathbone, J, 2015) |
| "To assess the effects of fluphenazine decanoate and enanthate versus oral anti-psychotics and other depot neuroleptic preparations for individuals with schizophrenia in terms of clinical, social and economic outcomes." | 4.91 | Fluphenazine decanoate (depot) and enanthate for schizophrenia. ( Adams, CE; Asher, R; David, A; Eisenbruch, M; Jayaswal, A; Maayan, N; Quraishi, SN; Rathbone, J, 2015) |
| "9% of the total antipsychotic dosage on average." | 1.39 | Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. ( Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T, 2013) |
| " To gather relevant data on pharmacokinetic characteristics of depot fluphenazines, the authors measured plasma levels of neuroleptic activity in 76 clinic patients on stable dosage regimens of fluphenazine decanoate or fluphenazine enanthate." | 1.27 | Plasma levels of neuroleptic in patients receiving depot fluphenazine. ( Chouinard, G; Cohen, BM; Jones, B; Sommer, BR; Waternaux, C, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchida, T | 1 |
| Suzuki, T | 1 |
| Sakurai, H | 1 |
| Tsutsumi, C | 1 |
| Den, R | 1 |
| Mimura, M | 1 |
| Uchida, H | 1 |
| Maayan, N | 1 |
| Quraishi, SN | 1 |
| David, A | 1 |
| Jayaswal, A | 1 |
| Eisenbruch, M | 1 |
| Rathbone, J | 1 |
| Asher, R | 1 |
| Adams, CE | 1 |
| Citrome, L | 1 |
| Jaffe, A | 1 |
| Levine, J | 1 |
| POLLACK, SL | 1 |
| TOURLENTES, TT | 1 |
| ZOCCHI, AF | 1 |
| RAVARIS, CL | 1 |
| WEAVER, LA | 1 |
| BROOKS, GW | 1 |
| BARSA, JA | 1 |
| SAUNDERS, JC | 1 |
| Chouinard, G | 2 |
| Annable, L | 1 |
| Ross-Chouinard, A | 1 |
| Hogan, TP | 1 |
| Awad, AG | 1 |
| Glazer, WM | 1 |
| Kane, JM | 1 |
| Guy, N | 1 |
| Raps, A | 1 |
| Assael, M | 1 |
| Altamura, AC | 1 |
| Curry, SH | 1 |
| Montgomery, S | 1 |
| Wiles, DH | 1 |
| Rampertaap, MP | 1 |
| Cohen, BM | 1 |
| Waternaux, C | 1 |
| Sommer, BR | 1 |
| Jones, B | 1 |
3 reviews available for fluphenazine enanthate and Schizophrenia
| Article | Year |
|---|---|
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Injec | 2015 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
4 trials available for fluphenazine enanthate and Schizophrenia
| Article | Year |
|---|---|
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Doub | 1982 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1985 |
9 other studies available for fluphenazine enanthate and Schizophrenia
| Article | Year |
|---|---|
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; H | 2013 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relati | 2010 |
CLINICAL TRIAL OF FLUPHENAZINE ENANTHATE-- A LONG-ACTING INJECTABLE TRANQUILIZER.
Topics: Biomedical Research; Fluphenazine; Humans; Hypnotics and Sedatives; Schizophrenia | 1964 |
A CONTROLLED STUDY OF FLUPHENAZINE ENANTHATE IN CHRONIC SCHIZOPHRENIC PATIENTS.
Topics: Biomedical Research; Delayed-Action Preparations; Drug Therapy; Fluphenazine; Geriatrics; Humans; In | 1965 |
A DOUBLE BLIND STUDY OF FLUPHENAZINE ENANTHATE.
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Therapy; Fluphenazine; Geriatrics; Humans; In | 1965 |
Pharmacotherapy and suicide risk in schizophrenia.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; H | 1983 |
The Pisa syndrome during maintenance antipsychotic therapy.
Topics: Adult; Antipsychotic Agents; Dystonia; Female; Fluphenazine; Humans; Schizophrenia | 1986 |
Vitiligo-like syndrome following the use of fluphenazine enanthate.
Topics: Adult; Female; Fluphenazine; Humans; Schizophrenia; Vitiligo | 1985 |
Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Regression Analysis; Schizophrenia | 1985 |